This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
In this tracker, Fierce Pharma is recording the regulatory progress of in-market...
If you ever find yourself doing outdoor hobbies in slow motion or bursting into ...
Despite President Donald Trump’s threat last week that tariffs on pharmaceutical...
In this tracker, Fierce Pharma is recording the regulatory progress of in-market...
Biotech news stories of the day, brought to you by The Readout.
Opinion/decision on a Paediatric investigation plan (PIP): Tenkasi (previously O...
Human medicines European public assessment report (EPAR): Rinvoq, upadacitinib, ...
As always, if you know of layoffs occurring at a biotech, please reach out to th...
Opinion/decision on a Paediatric investigation plan (PIP): Qarziba (previously D...
Quality Review of Documents (QRD) annotated template v11: Draft for public consu...
Quality Review of Documents (QRD) annotated template v11: Draft for public consu...
Gilead Sciences’ sponsorship of a conference Wi-Fi network has landed it in hot ...
Pfizer said it would stop development of danuglipron, its experimental oral GLP-...
We may be witnessing a remaking of biotech — including the famed Kendall Square ...
Opinion/decision on a Paediatric investigation plan (PIP): Lokelma, sodium zirco...
Third Harmonic Bio has abandoned plans to take its chronic spontaneous urticaria...
Opinion/decision on a Paediatric investigation plan (PIP): VidPrevtyn Beta, SARS...
US pharmaceutical group says patient in study ‘experienced potential drug-induce...